[Renin-angiotensin-aldosterone system: effect of the hypertensive agents on plasma renin activity and clinical application, especially in screening of primary aldosteronism and other simialr diseases].
D000293:Adolescent; D000328:Adult; D000450:Aldosterone / Q000652:urine; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D003714:Denervation; D003981:Diazoxide / Q000494:pharmacology* / Q000627:therapeutic use; D004285:Dogs; D005260:Female; D005919:Glomerular Filtration Rate; D006801:Humans; D006929:Hyperaldosteronism / Q000175:diagnosis*; D006973:Hypertension / Q000175:diagnosis; D007275:Injections, Intravenous; D007668:Kidney / Q000098:blood supply / Q000294:innervation; D008297:Male; D008875:Middle Aged; D011187:Posture; D011188:Potassium / Q000097:blood; D011674:Pulse / Q000187:drug effects; D012039:Regional Blood Flow / Q000187:drug effects; D012083:Renin / Q000097:blood*; D012964:Sodium / Q000652:urine
D000450:Aldosterone; D012964:Sodium; D012083:Renin; D003981:Diazoxide; D011188:Potassium